Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study.

Publication Type:

Journal Article

Source:

PloS one, Volume 10, Issue 3, p.e0121112 (2015)

Abstract:

Leucine-rich alpha-2-glycoprotein (LRG1) was found to be differentially expressed in sera from patients with Epithelial Ovarian Cancer (EOC). The aim of this study is to investigate the performance of LRG1 for detection of EOC, including early stage EOC, and to evaluate if LRG1 can complement CA125 in order to improve EOC detection using two independent blinded sample sets.